The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at NCI-Designated Cancer Centers.

ABSTRACT:

Introduction

The COVID-19 pandemic disrupted cancer screening and treatment delivery, but COVID-19's impact on tobacco cessation treatment for cancer patients who smoke has not been widely explored.

Methods

We conducted a sequential cross-sectional analysis of data collected from 34 NCI-designated cancer centers participating in NCI's Cancer Center Cessation Initiative (C3I), across three reporting periods: one prior to COVID-19 (January-June 2019) and two during the pandemic (January-June 2020, January-June 2021). Using McNemar's Test of Homogeneity, we assessed changes in services offered and implementation activities over time.

Results

The proportion of centers offering remote treatment services increased each year for Quitline referrals (56%, 68%, and 91%; p=.000)

SUBMITTER: Hohl SD 

PROVIDER: S-EPMC9384385 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature